PHP
MNKD icon

Parkman Healthcare Partners’s MannKind Corp MNKD Stock Holding History

Parkman Healthcare Partners’s Portfolio MNKD Stock Details MNKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-640,356
Closed -$3.63M – 103
2025
Q4 		$3.63M Sell
640,356
-15,728
-2% -$86.6K 0.35% 76
2025
Q3 		$3.52M Sell
656,084
-1,244,834
-65% -$5.46M 0.37% 71
2025
Q2 		$7.11M Sell
1,900,918
-592,918
-24% -$2.61M 0.82% 49
2025
Q1 		$12.5M Sell
2,493,836
-632,891
-20% -$3.55M 1.49% 27
2024
Q4 		$20.1M Sell
3,126,727
-177,358
-5% -$1.19M 2.68% 10
2024
Q3 		$20.8M Buy
3,304,085
+894,486
+37% +$5.14M 2.65% 8
2024
Q2 		$12.6M Buy
2,409,599
+3,663
+0.2% +$16.6K 1.68% 17
2024
Q1 		$10.9M Sell
2,405,936
-92,688
-4% -$364K 1.34% 29
2023
Q4 		$9.09M Buy
2,498,624
+429,677
+21% +$1.64M 1.28% 28
2023
Q3 		$8.54M Buy
2,068,947
+252,366
+14% +$1.13M 1.57% 19
2023
Q2 		$7.39M Buy
1,816,581
+342,483
+23% +$1.43M 1.28% 25
2023
Q1 		$6.04M Buy
1,474,098
+442,989
+43% +$2.14M 1.31% 32
2022
Q4 		$5.43M Buy
1,031,109
+106,130
+11% +$434K 1.45% 22
2022
Q3 		$2.86M Buy
924,979
+160,165
+21% +$604K 0.81% 45
2022
Q2 		$2.91M Buy
764,814
+89,411
+13% +$328K 1.07% 33
2022
Q1 		$2.48M Buy
675,403
+409,548
+154% +$1.5M 0.73% 45
2021
Q4 		$1.16M Buy
265,855
+10,808
+4% +$50K 0.26% 72
2021
Q3 		$1.11M Sell
255,047
-550,000
-68% -$2.48M 0.28% 64
2021
Q2 		$4.39M Buy
805,047
+405,047
+101% +$1.75M 0.96% 39
2021
Q1 		$1.57M Buy
+400,000
New +$1.64M 0.36% 64
2020
Q4 		– Sell
-351,230
Closed -$660K – 91
2020
Q3 		$660K Sell
351,230
-199,887
-36% -$346K 0.17% 75
2020
Q2 		$964K Sell
551,117
-350,000
-39% -$489K 0.27% 70
2020
Q1 		$928K Sell
901,117
-524,185
-37% -$708K 0.43% 55
2019
Q4 		$1.84M Buy
+1,425,302
New +$1.82M 0.53% 52

Other funds holding MNKD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Parkman Healthcare Partners's MNKD Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of MannKind Corp (MNKD) in Q1 2026, closing a stake of 640,356 shares — an estimated $3.63M sold.

Parkman Healthcare Partners first reported a position in MNKD in Q4 2019 and held it in 24 quarters. The position peaked at $20.8M in Q3 2024. 250 funds tracked by Wall St. Rank hold MNKD as of Q1 2026.

  • Parkman Healthcare Partners reported no remaining MannKind Corp position as of Q1 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 640,356 MannKind Corp shares in Q1 2026, an estimated $3.63M.
  • Parkman Healthcare Partners first reported a position in MannKind Corp in Q4 2019 and held it in 24 quarters.
  • Parkman Healthcare Partners's MannKind Corp position peaked at $20.8M in Q3 2024.
  • 250 funds tracked by Wall St. Rank held MannKind Corp as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.